News
Company News: BioNTech to Present at 36th Annual J.P. Morgan Healthcare Conference
BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of BioNTech, will be presenting at the 36th Annual J.P. Morgan Healthcare Conference that is being held in San Francisco, CA from January 8-11, 2018. The Company’s presentation is scheduled for Tuesday, January 9 at 9:00 AM Pacific Standard Time.
Mr. Marett will provide an overview of the Company´s strategy as well as an update on its development programs, including its expanding clinical pipeline, in-house manufacturing capabilities, and a summary of human clinical data recently published in Nature publication on its neo-epitope based individualized mRNA cancer immunotherapeutic.